Celcuity CELC has made significant clinical and regulatory progress in the past few months. In November, Celcuity submitted a new drug application (“NDA”) to the FDA seeking approval for its lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback